---

About

Andre Esteva is a researcher and entrepreneur in medical AI. He currently serves as CEO and Founder of ArteraAI, a growth-stage medical AI startup that personalizes therapy for cancer patients and is now standard of care (NCCN Guidelines), reimbursed by Medicare, and widely deployed internationally. He was previously the Head of Medical AI at Salesforce Research, and held engineering positions at Google Research, Sandia National Labs, and GE Healthcare. He has co-founded four companies (cumulative market cap: $2.2B).

With over 20,000 citations, his research efforts have largely focused on medical AI diagnostics and precision medicine. His publications have made the covers of Nature and Nature Medicine, and have been featured in Cell, The Lancet, NeurIPS, TIME, and similar venues. These works have been widely covered by the WSJ, Fortune, BBC, The Economist, and hundreds of other news outlets.

He obtained his PhD in Artificial Intelligence at Stanford, conducting research in medical AI. In a landmark publication that made the cover of Nature, he was the first to show that AI could match the performance of clinicians at medical diagnostics. He finished undergraduate degrees with highest honors in Electrical Engineering and Pure Math from UT-Austin and was awarded Engineering Valedictorian (formally, the Outstanding Scholar-Leader Award).

Select Companies

Select Publications